Effect of a Microprocessor-controlled Prosthetic Knee Joint on K2 Level Ambulators (MPK-K2)

Does a Microprocessor-Controlled Prosthetic Knee Joint Improve Mobility and Quality of Life in K2-Level Veteran Ambulators?

Microprocessor-controlled knees (MPKs) automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the prosthesis user during gait. The purpose of this proposed investigation is to determine if there are substantial physical and psychological benefits to fitting lower functioning Veteran ambulators having transfemoral amputations with an MPK compared with a nonmicroprocessor-controlled knee (NMPK). Using a repeated-measures, cross-sectional experimental design, approximately 20 Veterans with unilateral, transfemoral amputations will be evaluated on two separate occasions at the Jesse Brown VA Medical Center or the Edward Hines, Jr. VA Hospital, first with their conventional NMPK and then again after a 2-month accommodation period with the College Park Icon MPK.

Study Overview

Status

Not yet recruiting

Detailed Description

Limb loss is a potentially devastating event in a person's life, often resulting in profound physical, psychological, and vocational consequences. A transfemoral amputation results in greater physical and functional impairment and an increased risk of falling in patients as compared to someone with a transtibial amputation. Furthermore, balance confidence and fear of falling appears to be a persistent and pervasive problem among lower-limb prosthesis users, which adversely affects mobility and quality of life. During the past 30 years there have been several major developments in prosthetic knee mechanisms that incorporate microprocessors to improve swing-phase characteristics and provide greater stability during stance phase. Microprocessor-controlled knees (MPKs) automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the user during gait.

There are numerous reported benefits of MPKs over non-microprocessor controlled knees (NMPKs), including faster self-selected walking speeds, reduced cognitive burden while walking, fewer stumbles and falls, and increased perceptions of confidence and safety while ambulating. Nonetheless, MPKs are not typically prescribed or fitted on lower functioning ambulators, which is the activity classification of most Veteran patients.

The purpose of this proposed investigation is to determine if there are substantial physical and psychological benefits to fitting lower functioning Veteran ambulators having transfemoral amputations with an MPK compared with a NMPK. The specific aims and hypotheses of this project are:

Aim 1: To determine the effects of the College Park Icon on the mobility of unilateral, transfemoral prosthesis users. The investigators hypothesize that the MPK will enable users to 1) increase their freely-selected (i.e., normal) walking speed, and 2) walk over a wider range of speeds. Furthermore, the investigators hypothesize that 3) participants will report fewer falls with the MPK.

Aim 2: To determine the effects of the College Park Icon on the psychological well-being of unilateral, transfemoral prosthesis users. The investigators hypothesize that subjects will improve their scores on patient-reported outcome assessments including the ABC, OPUS, and PLUS-M with the MPK.

Aim 3: To determine subjects' preference for the College Park Icon compared to their conventional NMPK. At the completion of the study, the investigators will ask participants which prosthetic knee type they preferred. It's hypothesized that the majority of participants will prefer using the MPK over the NMPK. Those subjects who prefer the MPK will be permitted to keep the component in their prosthesis, while those who prefer their NMPK will have their prosthesis returned to its original configuration.

Using a cross-sectional experimental design, approximately 20 Veterans who are low functioning ambulators with unilateral, transfemoral amputations will be evaluated on two separate occasions at the Jesse Brown VA Medical Center or the Edward Hines, Jr. VA Hospital, first with their conventional NMPK and then again after a two-month accommodation period with the College Park Icon MPK.

This work is directly applicable to VHA's Patient Care Mission because the results may justify the fitting of MPKs on low-level ambulators within the VA system and substantially improve the mobility of Veterans with lower limb amputations while increasing their quality of life.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60612
        • Jesse Brown VA Medical Center, Chicago, IL
        • Contact:
        • Principal Investigator:
          • Steven A Gard, PhD
        • Contact:
      • Hines, Illinois, United States, 60141-3030
        • Edward Hines Jr. VA Hospital, Hines, IL
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Unilateral, transfemoral amputation (any etiology).
  • Age from 45-85 years.
  • Residual limb length classified as standard (i.e., medium) to long.
  • Prosthesis user for at least 1 year prior to enrolling in the study.
  • K2-level classification while using their NMPK.
  • Good sensation on their residual limb.
  • Good skin integrity upon visual inspection.
  • Presents with good socket fit based upon a standard assessment by the study prosthetist.

Exclusion Criteria:

  • Bilateral leg amputations.
  • Individuals with a knee disarticulation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MPK
Subjects will be fitted with the College Park ICON MPK and permitted to accommodate for 2 months prior to data collection.
Subjects will be fitted and trained on the College Park ICON MPK. An accommodation period of 2 months will be provided prior to evaluation with the knee joint.
Active Comparator: NMPK
Subjects will initially be evaluated walking on their conventional NMPK as a baseline prior to being fitted with the MPK.
Subjects will be tested walking with their conventional, mechanical prosthetic knee prior to being fitted with the MPK.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking speed
Time Frame: To be measured before and immediately following the 2-month accommodation period of wearing the MPK.
Walking speed will be measured as participants walk on level ground at slow, normal and fast speeds.
To be measured before and immediately following the 2-month accommodation period of wearing the MPK.
Falls during walking
Time Frame: To be determined before and during the 2-month accommodation period of wearing the MPK
The number of falls that occur while the subject is walking will be recorded in a daily diary.
To be determined before and during the 2-month accommodation period of wearing the MPK
PLUS-M
Time Frame: To be measured before and immediately following the 2-month accommodation period of wearing the MPK.
The Prosthetic Limb User Survey of Mobility (PLUS-M) will be used to determine the mobility of subjects before and after fitting with the MPK. Scores range from 12-60 points, and a higher score indicates greater mobility.
To be measured before and immediately following the 2-month accommodation period of wearing the MPK.
Prosthetic Knee Preference
Time Frame: To be asked immediately following the 2-month accommodation period of wearing the MPK.
Subjects will be asked which prosthetic knee they prefer at the completion of the study. For those that indicate preference for the MPK, they will be permitted to keep it in their prosthesis. For those that prefer the NMPK, their prosthesis will be restored to the configuration prior to beginning the study.
To be asked immediately following the 2-month accommodation period of wearing the MPK.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ABC Scale
Time Frame: To be administered before and immediately following the 2-month accommodation period of wearing the MPK.
The Activities-specific Balance Confidence (ABC) Scale measures the subject's confidence in not losing their balance or becoming unsteady while performing different activities. Scores range from 0-100%, where zero represents no confidence and 100 represents complete confidence in performing an activity without losing balance or becoming unsteady.
To be administered before and immediately following the 2-month accommodation period of wearing the MPK.
OPUS
Time Frame: To be administered before and immediately following the 2-month accommodation period of wearing the MPK.
The Orthotics and Prosthetics User's Survey (OPUS) is a self-report questionnaire that can be used for quality assessment, to maintain awareness of improvement in activities, to evaluate changes in patient's functional status and quality of life, and to assess satisfaction with devices and services. Scores range from 0-80 points, with a higher score indicating greater functional mobility.
To be administered before and immediately following the 2-month accommodation period of wearing the MPK.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Steven A Gard, PhD, Jesse Brown VA Medical Center, Chicago, IL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

June 30, 2028

Study Registration Dates

First Submitted

July 15, 2025

First Submitted That Met QC Criteria

July 31, 2025

First Posted (Actual)

August 5, 2025

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 7, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RRD2-005-24W
  • RX005610 (Other Grant/Funding Number: VA RRD)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Results from this study will be freely disseminated via presentations at professional conferences and publications in scientific journals. Additionally, data acquired for this project will be shared with those investigators who make a formal request to the PI and can demonstrate a legitimate and justifiable cause for utilization of such data. All requests for these data will be discussed with the VA scientific program manager.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transfemoral Amputation

Clinical Trials on College Park ICON

Subscribe